Golimumab News

Latest Articles

• IQWiG Assessment Finds No Added Benefit for Guselkumab Over Golimumab in Ulcerative Colitis Patients

  Published: Mar 28, 2026

  Section: Research

  The German Institute for Quality and Efficiency in Health Care (IQWiG) has concluded its benefit assessment for the monoclonal antibody guselkumab in treating ulcerative colitis. D...